|
1
|
Bhaijee F and Nikiforov YE: Molecular
analysis of thyroid tumors. Endocr Pathol. 22:126–133. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nikiforov YE: Molecular analysis of
thyroid tumors. Mod Pathol. 24(Suppl 2): S34–S43. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
World Health Organization Classification
of Tumors: Pathology and Genetics of Tumours of Endocrine Organs.
DeLellis RA, Lloyd RV, Heitz PU and Eng C: Lyon: IARC Press.
2004.
|
|
4
|
Nikiforov YE: Thyroid tumors:
classification and general considerations. Diagnostic pathology and
molecular genetics of the thyroid. Nikiforov YE, Biddinger PW and
Thompson LDR: (Baltimore, MD). Lippincott Williams & Wilkins.
94–102. 2009.
|
|
5
|
Gulcelik MA, Gulcelik NE, Kuru B, Camlibel
M and Alagol H: Prognostic factors determining survival in
differentiated thyroid cancer. J Surg Oncol. 96:598–604. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Roy M, Chen H and Sippel RS: Current
understanding and management of medullary thyroid cancer.
Oncologist. 18:1093–1100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hundahl SA, Cady B, Cunningham MP,
Mazzaferri E, McKee RF, Rosai J, Shah JP, Fremgen AM, Stewart AK
and Hölzer S: Initial results from a prospective cohort study of
5583 cases of thyroid carcinoma treated in the united states during
1996. U.S. and German Thyroid Cancer Study Group. An American
College of Surgeons Commission on Cancer Patient Care Evaluation
study. Cancer. 89:202–217. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thyroid Cancer Treatment (PDQR): Medullary
Thyroid Cancer. http://www.cancer.gov./cancertopics/pdq/treatment/thyroid/HealthProfessional/page7Accessed.
July 29–2013
|
|
9
|
Desailloud R and Hober D: Viruses and
thyroiditis: an update. Virol J. 6:52009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aozasa K, Ueda T, Katagiri S, Matsuzuka F,
Kuma K and Yonezawa T: Immunologic and immunohistologic analysis of
27 cases with thyroid lymphomas. Cancer. 60:969–973. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ron E and Schneider A: Thyroid cancer.
Cancer Epidemiology and Prevention. Schottenfeld D and Fraumeni J:
(New York, NY). Oxford University Press. 975–994. 2006. View Article : Google Scholar
|
|
12
|
Simard EP, Ward EM, Siegel R and Jemal A:
Cancers with increasing incidence trends in the United States: 1999
through 2008. CA Cancer J Clin. 62:118–128. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Davies L and Welch HG: Increasing
incidence of thyroid cancer in the United States, 1973–2002. JAMA.
295:2164–2167. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Davies L, Ouellette M, Hunter M and Welch
HG: The increasing incidence of small thyroid cancers: where are
the cases coming from? Laryngoscope. 120:2446–2451. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aschebrook-Kilfoy B, Ward MH, Sabra MM and
Devesa SS: Thyroid cancer incidence patterns in the United States
by histologic type, 1992–2006. Thyroid. 21:125–134. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen AY, Jemal A and Ward EM: Increasing
incidence of differentiated thyroid cancer in the United States,
1988–2005. Cancer. 115:3801–3807. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Enewold L, Zhu K, Ron E, Marrogi AJ,
Stojadinovic A, Peoples GE and Devesa SS: Rising thyroid cancer
incidence in the United States by demographic and tumor
characteristics, 1980–2005. Cancer Epidemiol Biomarkers Prev.
18:784–791. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ahmed R, Al-Shaikh S and Akhtar M:
Hashimoto thyroiditis: a century later. Adv Anat Pathol.
19:181–186. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Holm LE, Blomgren H and Löwhagen T: Cancer
risks in patients with chronic lymphocytic thyroiditis. N Engl J
Med. 312:601–604. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kimura ET, Nikiforova MN, Zhu Z, Knauf JA,
Nikiforov YE and Fagin JA: High prevalence of BRAF mutations in
thyroid cancer: Genetic evidence for constitutive activation of the
RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.
Cancer Res. 63:1454–1457. 2003.PubMed/NCBI
|
|
21
|
Soares P, Trovisco V, Rocha AS, Lima J,
Castro P, Preto A, Máximo V, Botelho T, Seruca R and
Sobrinho-Simões M: BRAF mutations and RET/PTC rearrangements are
alternative events in the etiopathogenesis of PTC. Oncogene.
22:4578–4580. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Frattini M, Ferrario C, Bressan P,
Balestra D, De Cecco L, Mondellini P, Bongarzone I, Collini P,
Gariboldi M, Pilotti S, et al: Alternative mutations of BRAF, RET
and NTRK1 are associated with similar but distinct gene expression
patterns in papillary thyroid cancer. Oncogene. 23:7436–7440. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Adeniran AJ, Zhu Z, Gandhi M, Steward DL,
Fidler JP, Giordano TJ, Biddinger PW and Nikiforov YE: Correlation
between genetic alterations and microscopic features, clinical
manifestations, and prognostic characteristics of thyroid papillary
carcinomas. Am J Surg Pathol. 30:216–222. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kroll TG, Sarraf P, Pecciarini L, Chen CJ,
Mueller E, Spiegelman BM and Fletcher JA: PAX8-PPARgamma1 fusion
oncogene in human thyroid carcinoma (corrected). Science.
289:1357–1360. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nikiforova MN, Lynch RA, Biddinger PW,
Alexander EK, Dorn GW II, Tallini G, Kroll TG and Nikiforov YE: RAS
point mutations and PAX8-PPAR gamma rearrangement in thyroid
tumors: evidence for distinct molecular pathways in thyroid
follicular carcinoma. J Clin Endocrinol Metab. 88:2318–2326. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fagin JA and Mitsiades N: Molecular
pathology of thyroid cancer: Diagnostic and clinical implications.
Best Pract Res Clin Endocrinol Metab. 22:955–969. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ricarte-Filho JC, Ryder M, Chitale DA,
Rivera M, Heguy A, Ladanyi M, Janakiraman M, Solit D, Knauf JA,
Tuttle RM, et al: Mutational profile of advanced primary and
metastatic radioactive iodine-refractory thyroid cancers reveals
distinct pathogenetic roles for BRAF, PIK3CA, and AKT1. Cancer Res.
69:4885–4893. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vasko V, Espinosa AV, Scouten W, He H,
Auer H, Liyanarachchi S, Larin A, Savchenko V, Francis GL, de la
Chapelle A, et al: Gene expression and functional evidence of
epithelial-to-mesenchymal transition in papillary thyroid carcinoma
invasion. Proc Natl Acad Sci USA. 104:2803–2808. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jensen K, Patel A, Larin A, Hoperia V,
Saji M, Bauer A, Yim K, Hemming V and Vasko V: Human herpes simplex
viruses in benign and malignant thyroid tumours. J Pathol.
221:193–200. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kaul R, Murakami M, Lan K, Choudhuri T and
Robertson ES: EBNA3C can modulate the activities of the
transcription factor Necdin in association with metastasis
suppressor protein Nm23-H1. J Virol. 83:4871–4883. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Horikawa T, Yang J, Kondo S, Yoshizaki T,
Joab I, Furukawa M and Pagano JS: Twist and epithelial-mesenchymal
transition are induced by the EBV oncoprotein latent membrane
protein 1 and are associated with metastatic nasopharyngeal
carcinoma. Cancer Res. 67:1970–1978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tsuji A, Wakisaka N, Kondo S, Murono S,
Furukawa M and Yoshizaki T: Induction of receptor for advanced
glycation end products by EBV latent membrane protein 1 and its
correlation with angiogenesis and cervical lymph node metastasis in
nasopharyngeal carcinoma. Clin Cancer Res. 14:5368–5375. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Strauss R, Sova P, Liu Y, Li ZY, Tuve S,
Pritchard D, Brinkkoetter P, Möller T, Wildner O, Pesonen S, et al:
Epithelial phenotype confers resistance of ovarian cancer cells to
oncolytic adenoviruses. Cancer Res. 69:5115–5125. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang X, Zhang Z, Zheng B, He Z, Winberg G
and Ernberg I: An update on viral association of human cancers.
Arch Virol. 158:1433–1443. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
McLaughlin-Drubin ME and Munger K: Viruses
associated with human cancer. Biochim Biophys Acta. 1782:127–150.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Feng H, Shuda M, Chang Y and Moore PS:
Clonal integration of a polyomavirus in human Merkel cell
carcinoma. Science. 319:1096–1100. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Dalianis T and Hirsch HH: Human
polyomaviruses in disease and cancer. Virology. 437:63–72. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gjoerup O and Chang Y: Update on human
polyomaviruses and cancer. Adv Cancer Res. 106:1–51. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cheng J, DeCaprio JA, Fluck MM and
Schaffhausen BS: Cellular transformation by Simian Virus 40 and
Murine Polyoma Virus T antigens. Semin Cancer Biol. 19:218–228.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Abend JR, Jiang M and Imperiale MJ: BK
virus and human cancer: innocent until proven guilty. Semin Cancer
Biol. 19:252–260. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Imperiale MJ: The human polyomaviruses,
BKV and JCV: Molecular pathogenesis of acute disease and potential
role in cancer. Virology. 267:1–7. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Imperiale MJ: Oncogenic transformation by
the human polyomaviruses. Oncogene. 20:7917–7923. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tognon M, Corallini A, Martini F, Negrini
M and Barbanti-Brodano G: Oncogenic transformation by BK virus and
association with human tumors. Oncogene. 22:5192–5200. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pacini F, Vivaldi A, Santoro M, Fedele M,
Fusco A, Romei C, Basolo F and Pinchera A: Simian virus 40-like DNA
sequences in human papillary thyroid carcinomas. Oncogene.
16:665–669. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Vivaldi A, Pacini F, Martini F, Iaccheri
L, Pezzetti F, Elisei R, Pinchera A, Faviana P, Basolo F and Tognon
M: Simian virus 40-like sequences from early and late regions in
human thyroid tumors of different histotypes. J Clin Endocrinol
Metab. 88:892–899. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ozdarendeli A, Camci C, Aygen E, Kirkil C,
Toroman ZA, Dogru O and Doymaz MZ: SV40 in human thyroid nodules. J
Clin Virol. 30:337–340. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Stamatiou D, Derdas SP, Symvoulakis EK,
Sakorafas GH, Zoras O and Spandidos DA: Investigation of BK virus,
Epstein-Barr virus and human papillomavirus sequences in
postoperative thyroid gland specimens. Int J Biol Markers.
30:e104–e110. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sweet BH and Hilleman MR: The vacuolating
virus, S.V. 40. Proc Soc Exp Biol Med. 105:420–427. 1960.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Grinde B: Herpesviruses: latency and
reactivation - viral strategies and host response. J Oral
Microbiol. 5:2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Dreyfus DH: Herpesviruses and the
microbiome. J Allergy Clin Immunol. 132:1278–1286. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Farooq AV and Shukla D: Herpes simplex
epithelial and stromal keratitis: An epidemiologic update. Surv
Ophthalmol. 57:448–462. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Rozenberg F, Deback C and Agut H: Herpes
simplex encephalitis: From virus to therapy. Infect Disord Drug
Targets. 11:235–250. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zerr DM, Meier AS, Selke SS, et al: A
population-based study of primary human herpesvirus 6 infection. N
Engl J Med. 352:768–776. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Townsend CL, Forsgren M, Ahlfors K,
Ivarsson SA, Tookey PA and Peckham CS: Long-term outcomes of
congenital cytomegalovirus infection in Sweden and the United
Kingdom. Clin Infect Dis. 56:1232–1239. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Boshoff C and Weiss R: AIDS-related
malignancies. Nat Rev Cancer. 2:373–382. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Sarid R and Gao SJ: Viruses and human
cancer: From detection to causality. Cancer Lett. 305:218–227.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Kutok JL and Wang F: Spectrum of
Epstein-Barr virus-associated diseases. Annu Rev Pathol. 1:375–404.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Deshmane SL and Fraser NW: During latency,
herpes simplex virus type 1 DNA is associated with nucleosomes in a
chromatin structure. J Virol. 63:943–947. 1989.PubMed/NCBI
|
|
59
|
Wilson AC and Mohr I: A cultured affair:
HSV latency and reactivation in neurons. Trends Microbiol.
20:604–611. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Given D, Yee D, Griem K and Kieff E: DNA
of Epstein-Barr virus. V. Direct repeats of the ends of
Epstein-Barr virus DNA. J Virol. 30:852–862. 1979.PubMed/NCBI
|
|
61
|
Cai X, Schafer A, Lu S, Biello JP,
Desrosiers RC, Edwards R, Raab-Traub N and Cullen BR: Epstein-Barr
virus microRNAs are evolutionarily conserved and differentially
expressed. PLoS Pathog. 2:e23Epub. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Fuentes-González AM, Contreras-Paredes A,
Manzo-Merino J and Lizano M: The modulation of apoptosis by
oncogenic viruses. Virol J. 10:1822013. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Takahashi K, Kashima K, Daa T, Yokoyama S,
Nakayama I and Noguchi S: Contribution of Epstein-Barr virus to
development of malignant lymphoma of the thyroid. Pathol Int.
45:366–374. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Tomita Y, Ohsawa M, Kanno H, Matsuzuka F,
Kuma K and Aozasa K: Sporadic activation of Epstein-Barr virus in
thyroid lymphoma. Leuk Lymphoma. 19:129–134. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Lam KY, Lo CY, Kwong DL, Lee J and
Srivastava G: Malignant lymphoma of the thyroid. A 30-year
clinicopathologic experience and an evaluation of the presence of
Epstein-Barr virus. Am J Clin Pathol. 112:263–270. 1999.PubMed/NCBI
|
|
66
|
Shimakage M, Kawahara K, Sasagawa T, Inoue
H, Yutsudo M, Yoshida A and Yanoma S: Expression of Epstein-Barr
virus in thyroid carcinoma correlates with tumor progression. Hum
Pathol. 34:1170–1177. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Kijima Y, Hokita S, Takao S, Baba M,
Natsugoe S, Yoshinaka H, Aridome K, Otsuji T, Itoh T, Tokunaga M,
et al: Epstein-Barr virus involvement is mainly restricted to
lymphoepithelial type of gastric carcinoma among various epithelial
neoplasms. J Med Virol. 64:513–518. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Ludvíková M, Ryska A, Korabecná M, Rydlová
M and Michal M: Oncocytic papillary carcinoma with lymphoid stroma
(Warthin-like tumour) of the thyroid: a distinct entity with
favourable prognosis. Histopathology. 39:17–24. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Tsai JH, Tsai CH, Cheng MH, Lin SJ, Xu FL
and Yang CC: Association of viral factors with non-familial breast
cancer in Taiwan by comparison with non-cancerous, fibroadenoma,
and thyroid tumor tissues. J Med Virol. 75:276–281. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Feigenbaum L, Hinrichs SH and Jay G: JC
virus and simian virus 40 enhancers and transforming proteins: Role
in determining tissue specificity and pathogenicity in transgenic
mice. J Virol. 66:1176–1182. 1992.PubMed/NCBI
|
|
71
|
Ledent C, Dumont J, Vassart G and
Parmentier M: Thyroid adenocarcinomas secondary to tissue-specific
expression of simian virus-40 large T-antigen in transgenic mice.
Endocrinology. 129:1391–1401. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Bond JA, Ness Oddweig G, Rowson J, Ivan M,
White D and Wynford-Thomas D: Spontaneous de-differentiation
correlates with extended lifespan in transformed thyroid epithelial
cells: An epigenetic mechanism of tumour progression? Int J Cancer.
67:563–572. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zuo F and Mertz JE: Simian virus 40 late
gene expression is regulated by members of the steroid/thyroid
hormone receptor superfamily. Proc Natl Acad Sci USA. 92:8586–8590.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Zuo F, Kraus RJ, Gulick T, Moore DD and
Mertz JE: Direct modulation of simian virus 40 late gene expression
by thyroid hormone and its receptor. J Virol. 71:427–436.
1997.PubMed/NCBI
|
|
75
|
Farrell ML and Mertz JE: Cell
type-specific replication of simian virus 40 conferred by hormone
response elements in the late promoter. J Virol. 76:6762–6770.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
schmutzler C, Brtko J, Winzer R, Jakobs
TC, Meissner-Weigl J, Simon D, Goretzki PE and Köhrle J: Functional
retinoid and thyroid hormone receptors in human thyroid-carcinoma
cell lines and tissues. Int J Cancer. 76:368–376. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Puzianowska-Kuznicka M, Krystyniak A,
Madej A, Cheng SY and Nauman J: Functionally impaired TR mutants
are present in thyroid papillary cancer. J Clin Endocrinol Metab.
87:1120–1128. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Hirsch HH and Steiger J: Polyomavirus BK.
Lancet Infect Dis. 3:611–623. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Matsubayashi S, Tamai H, Morita T, Mori K,
Katsuki T, Matsuzuka F, Kuma K and Nagataki S: Malignant lymphoma
of the thyroid and Epstein-Barr virus. Endocrinol Jpn. 36:343–348.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Bayliss GJ and Wolf H: An Epstein - Barr
virus early protein induces cell fusion. Proc Natl Acad Sci USA.
78:7162–7165. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Yoshiyama H, Imai S, Shimizu N and Takada
K: Epstein-Barr virus infection of human gastric carcinoma cells:
implication of the existence of a new virus receptor different from
CD21. J Virol. 71:5688–5691. 1997.PubMed/NCBI
|
|
82
|
Sixbey JW, Shirley P, Chesney PJ, Buntin
DM and Resnick L: Detection of a second widespread strain of
Epstein-Barr virus. Lancet. 2:761–765. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Chan JK, Hui PK, Yip TT, Tsang WY, Law CK,
Poon YF and Ma VW: Detection of Epstein-Barr virus only in
lymphoepithelial carcinomas among primary carcinomas of the lung.
Histopathology. 26:576–578. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Margolis TP, Imai Y, Yang L, Vallas V and
Krause PR: Herpes simplex virus type 2 (HSV-2) establishes latent
infection in a different population of ganglionic neurons than
HSV-1: role of latency-associated transcripts. J Virol.
81:1872–1878. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Shah KM and Young LS: Epstein-Barr virus
and carcinogenesis: Beyond Burkitt's lymphoma. Clin Microbiol
Infect. 15:982–988. 2009. View Article : Google Scholar : PubMed/NCBI
|
